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Malaria is one of the most common parasitic dis-
eases worldwide and half of the world’s popula-
tion lives in areas where they ar e at the risk of 
this disease (1-3). As reported by the WHO in 
2016, 212 million new cases of malaria (144 to 
304 million people) were observed in the world; 
of all new cases, 90%, 7%, and 2% occurred in 
Africa, south-east Asia, and east Mediterranean 
region, respectively(4). In the same year, 429 
thousand people (235 to 639 thousand people) 
Abstract 
Background: This study aimed at estimating the incidence, mortality, burden, and geographical distribution of 
malaria between 2002 and 2015 in Iran.  
Methods: DALYs index was used to estimate the burden of malaria. DALYs-related malaria was calculated 
using a method developed by (WHO) for investigating the Global Burden of Disease (GBD); it was calculated 
through adding Years of Life Lost (YLLs) due to premature death to Years Lived with Disability (YLDs).The 
data on the incidence and mortality were collected from the malaria surveillance system in the Center for Com-
municable Diseases Control (CCDC), Ministry of Health and Medical Education (MOHME). 
Results: The incidence of malaria had a decreasing trend over the studied period and it reduced from 15378 
cases in 2002 to 777 cases in 2015. Overall, 28 cases of mortality were observed between 2002 and 2015. In 
addition, disease burden decreased from 90.78 DALYs in 2002 to 22.38 DALYs in 2015.Overall, there were 
949.2 DALYs due to malaria from 2002 to 2015. The incidence and burden of malaria were not equally distrib-
uted among all the provinces in Iran and some areas were suffering from the highest burden of the disease.  
Conclusion: The incidence and burden of malaria have had a decreasing trend over the years of the study and 
Iran has little to do in order to eradicate malaria. Since the disease is not equally distributed among various 
provinces of Iran, health policymakers must direct health resources towards specific areas of the country (Sistan 
and Baluchistan, Kerman, and Hormozgan) with high concentration of cases of malaria. 
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died of malaria. The highest and the lowest mor-
tality rates were observed in Africa (92%), and 
Southeast Asia (6%) and east Mediterranean re-
gion (2%). Because of the implementation of 
some preventive measures, malaria incidence and 
mortality reduced from 21% in 2010 to 29% in 
2015, respectively (2, 4). As stated by Margaret 
Chan, the former Director-General of the WHO, 
"we owe this great achievement to better equipment, politi-
cal commitment, prosperous regional actions, and 
significant increase in national and international 
budgets"(5). 
The WHO adopted "Global Technical Strategy 
for Malaria 2016-2030" to deal with challenges 
related to malaria. The strategy sets out ambitious 
but feasible targets, including a 40% reduction in 
malaria incidence and mortality in the world by 
2020, disease eradication in at least 10 countries 
by 2020, and prevention reemergence of new 
cases in countries where the disease has been 
eradicated (6). In Iran, malaria is reported endem-
ic in some areas. A significant portion of Iran's 
geography has the potential climate for malaria 
transmission. Moreover, Iran's neighboring coun-
tries like Afghanistan (7, 8), Pakistan (9, 10) and 
Iraq (11) are the sources of the transmission of 
malaria into the country through immigrants (12, 
13). 
Disability-Adjusted Life Years (DALYs) is an 
index developed by the WHO, World Bank, and 
Health School of Harvard University for calculat-
ing the burden of diseases (14-16). Estimating the 
burden of diseases helps health sector authorities 
to better allocate health resources, set goals and 
focus on high-risk areas, and evaluate health care 
interventions (17-19). Based on a global report 
on the disease burden, the global rate of DALYs 
caused by malaria was 69138000 in 1990, 
90438100 in 2005, 82685000 in 2010, and 
55769600 in 2015.According to this report, ma-
laria was the 7th leading cause of global burden of 
diseases in 1990, 2005, and 2010 and 14th leading 
cause in 2015 (15, 20).  
In order to evaluate the effectiveness of interven-
tions implemented to fight malaria, it is necessary 
to estimate the incidence, mortality, and burden 
of the disease at national and provincial levels. To 
our knowledge, no study has ever been conduct-
ed in Iran to estimate the burden of malaria. 
Thus, this study is the first national study that 
aimed at estimating the incidence and burden of 
malaria at national and provincial levels. In addi-
tion, our study investigated the incidence and 
burden of malaria over a 14-year period. There-
fore, it can be a comprehensive and authentic 
document for representing the status of malaria 




Disability-Adjusted Life Years (DALYs) index 
and the Global Burden of Disease method devel-
oped by the WHO were used for calculating the 
burden of malaria (21). DALYs is calculated 
through adding Years of Life Lost due to prema-
ture death (YLLs) to Years of Life Lost due to 
disability (YLDs) (18). 
 DALY= YLL+ YLD 
YLL is the number of deaths (N) multiplied by 
Iranian life expectancy at the age of death in 
years 
YLL=N × L 
The data on the incidence and mortality from 
2002 to 2015 were obtained from the malaria 
surveillance system in the Centre for Communi-
cable Diseases Control (CCDC), Ministry of 
Health and Medical Education (MOHME). The 
age weights were not included in the calculations; 
however, a discount rate of 0.03 was applied for 
discounting health values in future years (19). For 
each age group, the mean age of that group was 
considered as the mortality age for patients died 
of malaria. However, the mean mortality ages for 
the two age groups of 0-1 and 1-5 were set at 0.1 
and 2.6, respectively. Life expectancy remaining 
for each age group was calculated using life tables 
of Iranians reported by the WHO.  
YLD was calculated through multiplying the 
number of incident cases (I) by the average dura-
tion of the disease until remission or death (D) 
multiplied by Disability Weight (DW). 
YLD= I ×DW × D 
After holding an expert panel, the average period 
of the disease was set to be 12 d (0.0329 years). 
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We also used the special disability weight for each 
age group (Table 1) (22). Disability weight varies 
from 0 (complete health) to 1 (death). 
The data on the population of the country and its 
provinces during the period of the study was ob-
tained from the Statistical Center of Iran23). For 
the years without a census, the size of population 
was estimated based on the population growth 
rate. The data were analyzed using Excel software 
(ver. 2010). 
 
Table 1: Disability weight of malaria for various age groups 
 
Age group (yr) 0-4 5-14 15+ 




Table 2 presents the incidence, mortality, and 
burden of malaria by sex from 2002 to 2015. The 
incidence of malaria had a decreasing trend for 
both sexes. Overall, 11437 males and 3941 fe-
males were suffering from malaria in 2002. In 
2015, it reduced to 651 males and 126 fe-
males.During the years under study, six deaths 
from malaria were reported in the country: three 
of them occurred in people with non-Iranian na-
tionalities (2 Afghans and 1 Pakistani) infected 
with the disease out of Iran. The disease burden 
among males was always higher than that among 
females.The burden of malaria among females 
reduced from 23.26 DALYs in 2002 to 0.96 
DALYs in 2015. The same trend was also ob-
served among males; it reduced from 67.52 
DALYs in 2002 to 21.42 DALYs in 2015. Over-
all, DALYs-related malaria per 1000000 popula-
tion reduced from 1.370 to 0.284 over a 14-year 
period. 
 
Table 2: Incidence, mortality, and burden of malaria (DALYs) by sex during 2002-2015 
 




Total YLL Total 
YLD 
Total DALYs DALYs/1000000 
Population 
2002 Male 11437 0 0.00 67.52 67.52 1.370 
Female 3941 0 0.00 23.26 23.26 
2003 Male 17154 0 0.00 101.76 101.76 2.201 
Female 7844 0 0.00 46.46 46.46 
2004 Male 9417 0 0.00 55.88 55.88 1.140 
Female 3749 0 0.00 22.19 22.19 
2005 Male 12627 0 0.00 75.25 75.25 1.651 
Female 6658 0 0.00 39.65 39.65 
2006 Male 9924 0 0.00 59.59 59.59 1.351 
Female 5945 0 0.00 35.68 35.68 
2007 Male 10272 0 0.00 61.65 61.65 1.386 
Female 6217 0 0.00 37.31 37.31 
2008 Male 7786 0 0.00 46.38 46.38 0.932 
Female 3536 0 0.00 21.02 21.02 
2009 Male 4062 0 0.00 24.06 24.06 0.479 
Female 1858 0 0.00 11.01 11.01 
2010 Male 2361 0 0.00 13.99 13.99 0.237 
Female 602 0 0.00 3.57 3.57 
2011 Male 2564 0 0.00 14.96 14.96 0.254 
Female 707 0 0.00 4.12 4.12 
2012 Male 1479 2 55.10 10.33 65.43 0.891 
Female 323 0 0.00 2.35 2.35 
2013 Male 1130 2 55.15 1.74 56.89 0.763 
Female 262 0 0.00 1.85 1.85 
2014 Male 1050 1 26.21 7.35 33.56 0.450 
Female 204 0 0.00 1.45 1.45 
2015 Male 651 1 16.91 4.51 21.42 0.284 
Female 126 0 0.00 0.96 0.96 
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Fig. 1 presents the trend of the incidence of malaria 
by sex from 2002 to 2015. Fig. 2 presents the burden 
of malaria in both sexes over the studied period. 
Fig. 3 presents the share of YLL and YLD from 
the total DALYs caused by malaria over the stud-
ied period. Due to the lack of reports on death 
between 2002 and 2011, the share of YLL from 
the total DALYs was zero. However, the share of 
YLL form the total DALYs varied from about 
5% to 75%-94% between 2012 and 2015.  
 
 








Fig. 3: Share of YLL and YLD in the burden of malaria (DALYs) during 2002-2015 
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In 2006, Hormozgan (2.54 DALYs/100000 pop-
ulation), Sistan and Baluchistan (2.45 
DALYs/100000 population), and Kerman (0.37 
DALYs/100000 population) had the highest 
burden of malaria. In the same year, there was no 
case of malaria in Ilam, Kermanshah, Kurdistan, 
Hamedan, Zanjan, West Azerbaijan, and North 
Khorasan of the 15869 cases with malaria in 
2006, the provinces of Sistan and Baluchistan 
(8317 cases), Hormozgan (5009 cases), Kerman 
(1363 cases), and Fars (514 cases) had the highest 
proportion of the patients. More than 17% of the 
reported patients in the country (2769) were non-
Iranians (1617 Afghans, 1142 Pakistanis, and 10 
from other countries) and acquired malaria out-
side Iran. (Fig. 4). 
In 2011, the highest burden of malaria was ob-
served in Sistan and Baluchistan (0.65 
DALYs/100000 population) and Hormozgan 
(0.15 DALYs/100000 population). In the same 
year, there was no case of malaria in Ilam, Zanjan, 
West Azerbaijan, Tehran, and Alborz (Fig. 5). Of 
the 3271 cases with malaria in 2011, Sistan and 
Baluchestan Province (2383 cases), Hormozgan 
(351 cases), Fars (144 cases), Bushehr (53 cases), 





Fig. 4: Geographical distribution of the burden of 
malaria by DALYs/100000 population in all provinc-
es of Iran, in 2006 
 
About 48% of the reported cases in the country 
(1568 cases) were non-Iranians (577 Afghans, 966 
Pakistanis, and 10 from other countries) and ac-
quired malaria outside Iran. 
In 2015, the highest burden of malaria was ob-
served in Tehran (0.13 DALYs/100000 popula-
tion) and Sistan and Baluchistan (0.11 
DALYs/100000population). In the same year, 
there was no case of malaria in South Khorasan, 
North Khorasan, Semnan, Chaharmahal 
Bakhtiari, Kohgiluyeh and Boyer Ahmad, Hame-
dan, Kurdistan, Ilam, Kermanshah, Lorestan, 
Markazi, Zanjan, East Azerbaijan, Ardebil, Ma-
zandaran, and Guilan (Fig. 6). Of the 777 cases 
with malaria in 2015, the provinces of Sistan and 
Baluchistan (448 cases), Bushehr (81 cases), Fars 
(76 cases) and Hormozgan (54 cases) had the 
highest proportion of the disease. In 2015, only 
one death occurred due to malaria in the country 
(Tehran Province) and the patient had been in-
fected abroad. More than 50% of the patients 
reported in the country (359 cases) were non-
Iranians (270 cases of Afghans, 151 cases of Pa-
kistanis, and 8 from other countries) and malaria-




Fig. 5: Geographical distribution of the burden of 
malaria by DALYs/100000 population in all provinc-
es of Iran, in 2011
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The results of our study showed a dramatic de-
crease in the incidence and burden of malaria in 
Iran between 2002 and 2015. In 2002, the inci-
dence and burden of malaria were 15378 cases 
(2.32 per 10000 population) and 90.78 DALYs 
(0.28 per 1000000 population), respectively. 
However, in 2015, they reduced to 777 cases and 
22.38 DALYs, respectively. This downward trend 
demonstrates the success of interventions and 
programs to combat malaria. It is also partially 
due to climate change, such as warming the cli-
mate and reducing rainfall (24). In order to 
achieve the goal of malaria eradication, it is nec-
essary to adopt measures such as controlling bor-
der areas to prevent the transfer of patients from 
outside into the country, strengthening inter-
institutional and inter-sectoral cooperation, and 
strengthening health systems for the rapid identi-
fication of possible epidemics and adopting ap-
propriate interventions. A similar decreasing 
trend was observed in the world, too. In addition, 
number of DALYs caused by malaria had a 
38.3% reduction between 2005 and 2010 (15, 20). 
Of course, this reduction in the malaria incidence 
and number of DALYs in Iran is larger than that 
observed in the world; it indicated the success 
and effectiveness of interventions carried out in 
Iran to prevent or control malaria. In Sudan, the 
estimated incidence and burden of malaria were 9 
million cases (282 cases per 1000 population) and 
2.877 million DALYs (191.33 per 1000 popula-
tion), respectively (25). In Quanda city of Zimba-
bwe, the incidence of malaria was 2.12, 0.63, 0.99, 
1.43, and 0.49 per 1000 population from 2011 to 
2015, respectively. In addition, number of 
DALYs caused by malaria was 153.47, 0.22, 0.35, 
27,25, and 0.18 per 1000000 population in the 
same years of the study, respectively. Number of 
DALYs was reduced in Quanda over the studied 
period (22). 
Results of our study indicated that, on average, 
each case of malaria led to 0.007 loss of DALYs. 
This loss was 0.320 DALYs in Sudan in 2002(17) 
and 0.349 DALYs in Zimbabwe from 2011 to 
Iran J Public Health, Vol. 48, Supple.1, Mar 2019, pp. 53-61 
59                                                                                                          Available at:    http://ijph.tums.ac.ir 
2015 (22). The observed difference can be at-
tributed to the high mortality rate of malaria in 
Sudan (0.00488 in 2002) and Quanda (0.00834 
over five years of study) as compared withIran 
(0.00004 over a 14-year study period). Because of 
the lack of reports on the number of deaths 
caused by malaria in Iran between 2002 and 2011, 
the share of YLD from DALYs was 100%. 
However, between 2012 and 2015, since six 
deaths were reported, this percentage varied from 
13% to 21%. The share of YLD from the total 
DALYs was 3% in Sudan in 2002 (25). In Quan-
da, the share of YLD from the total DALYs was 
0.05%, 100%, 100%, 2%, 100%, from 2011 to 
2015, respectively (22). 
According to the results of our study, the inci-
dence, mortality, and number of DALYs lost due 
to malaria were higher in males, as compared 
with females. These findings are in line with 
results of a study (22). Moreover, in Sudan, the 
incidence and mortality of malaria in males were 
more than that in females; however, the number 
of DALYs lost due to malaria was higher among 
females than males (25). Based on the findings of 
our study, the incidence and burden of malaria 
varied between different provinces of Iran, and 
the high share of the incidence and burden of 
this disease was observed in several provinces of 
the country, including Sistan and Baluchistan, 
Hormozgan, Bushehr, Fars, and Kerman. To 
prevent, control, and eliminate malaria, policy-
makers and health managers should pay special 
attention to these provinces. During the studied 
years, the incidence of malaria in specific prov-
inces (with the highest incidence) decreased sig-
nificantly. For instance, the incidence of malaria 
between 2002 and 2015 varied from 6,394 to 448 
in Sistan and Baluchistan, from 2695 to 54 in 
Hormozgan, from 1609 to 23 in Kerman, de-
creased 321 to 81 in Bushehr, and from 1073 to 
76, in Fars, decreased. A significant percentage of 
reported cases of malaria in Iran occurred among 
non-Iranians or they had been infected outside 
Iran; accordingly, it has been 17% (2769 out of 
15869 cases) in 2006, 48% (1568 out of 3271 cas-
es) in 2011, and 51% (359 out of 777 cases), re-
spectively. In addition, more than 98% of the 
new cases were transmitted from Pakistan and 
Afghanistan. Therefore, it is necessary to consid-
er the border areas, quarantine, and visit travelers 
and individuals entering the country from Af-
ghanistan, Pakistan, and Iraq, and provide anti-
malarial drugs to travelers to these countries and 
other malaria-endemic countries to prevent and 




The incidence of malaria and the number of 
DALYs lost due to it did not have an equal distri-
bution in Iran. The main burden of malaria is ob-
served in some specific provinces. Iran has little to 
do in order to eradicate malaria, therefore, health 
authorities and policy-makers should direct the 
resources towards provinces where are the foci of 
malaria. Although the number of cases with malar-
ia has reduced in the country and the disease is 
close to being eradicated, we still must pay enough 
attention to this disease and keep it as an agenda 
for health policymakers. Neighboring with coun-
tries such as Afghanistan and Pakistan, as the 
countries at high risk of malaria and the risk of 
treatment-resistant malaria threaten the success of 
steps taken in Iran and in the world to reduce the 
incidence of the disease. If we do not pay enough 
attention to these issues, the incidence and mortal-
ity rate of malaria will rise again. In addition, with 
a reduction in the number of cases with malaria, 
per capita cost spent for reducing every case of 
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